Related Experiment Videos
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study
N K Arden1, C Price, I Reading
1Medical Research Council Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK. nka@mrc.soton.ac.uk
Rheumatology (Oxford, England)
|July 21, 2005
Summary
Lumbar epidural corticosteroid injections (ESI) provided short-term sciatica symptom relief but no long-term benefits for pain or function. A multidisciplinary approach is recommended for managing chronic sciatica.
Area of Science:
- Pain Management
- Neurology
- Orthopedics
Background:
- Sciatica is a common condition causing significant pain and disability.
- Lumbar epidural corticosteroid injections (ESI) are frequently used to treat sciatica.
- Predictors of response to ESI in sciatica patients require further investigation.
Purpose of the Study:
- To evaluate the effectiveness of lumbar epidural corticosteroid injections (ESI) for sciatica.
- To identify predictors of treatment response to ESI in sciatica patients.
- To assess the long-term impact of ESI on pain, function, and surgical need.
Main Methods:
- A 12-month, multicentre, double-blind, randomized, placebo-controlled trial was conducted.
- 228 patients with unilateral sciatica received either three lumbar ESIs or saline injections.
- The Oswestry low back pain disability questionnaire (ODQ) was the primary outcome measure.
Main Results:
- ESI showed a transient benefit at 3 weeks (12.5% vs 3.7% improvement in ODQ).
- No significant benefits were observed from 6 to 52 weeks post-injection.
- ESI did not improve physical function, return to work, or reduce the need for surgery; no predictors of response were identified.
Conclusions:
- Lumbar ESIs offer only temporary symptom relief for sciatica.
- Sustained benefits in pain, function, or surgical outcomes were not demonstrated.
- Sciatica management necessitates a multidisciplinary approach, with ESI evaluated within this context.